View Cart (0 items)


Clinicians and members of the renal care team get up-to-date news on the latest drug trials, research, treatment, and health care trends


Investigational drug reduces hyperkalemia levels in chronic kidney disease patients

The investigational drug patiromer decreased high potassium levels and maintained normal potassium levels in patients with chronic kidney disease

Read More

Exercise may improve physical function, lessen pain in patients with kidney disease

Study finds aerobic exercise safe and effective in patients with chronic kidney disease

Read More

Air pollution associated with higher rates of chronic kidney disease

To see if air quality may also play a role, Jennifer Bragg-Gresham, PhD, from the University of Michigan, and her colleagues looked at 2010 Medicare information on 1.1 million persons as well as air-quality data for all U.S. counties provided by the Environmental Protection Agency

Read More

Clinicians provide first successful delivery of dialysis in Ebola virus disease

Clinicians presented the protocol used to perform the first known successful delivery of renal replacement therapy with subsequent recovery of kidney function in a patient with Ebola at ASN Kidney Week 2014

Read More

Exercise benefits patients with chronic kidney disease

Simple exercises can help improve the health of patients with kidney disease, according to studies presented at the American Society of Nephrology's Kidney Week 2014.

Read More

Access to specialized kidney care varies by geographic area and race

Patients’ access to specialized care before kidney failure develops varies significantly across the United States and among different racial groups, according to two studies presented at ASN Kidney Week 2014

Read More

Rates of diabetic kidney disease may be underestimated

Diabetic kidney disease may be more common than currently assumed according to new research presented at ASN Kidney Week 2014

Read More

Two drugs are no more effective than one to treat polycystic kidney disease

Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease, according to two studies funded by the National Institutes of Health

Read More

Study: Extending weekly dialysis hours doesn't impact quality of life, but improves lab measures

Among 200 patients on dialysis, extending weekly dialysis hours for 12 months did not improve quality of life, but was linked with improvements in some laboratory measures

Read More

Frequent home dialysis provides survival advantage over in-center hemodialysis

Frequent home hemodialysis provides the best survival rate, but the modality has the poorest survival rate when offered only three times a week

Read More